Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 859
Active & Responsive
MicroRNA Correlates of Childhood Maltreatment and Suicidality
for
Major Depressive Disorder, Suicidal Ideation
Location: Birmingham AL, Huntsville AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 60
Code: NCT04923685
Recruiting
Active & Responsive
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
for
Anemia, Sickle Cell, Healthy Volunteers
Location: Birmingham AL, Atlanta GA, Richmond VA, Fairfax VA,
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
for
Alpha1-Antitrypsin Deficiency
Location: Birmingham AL, Nashville TN, New Orleans LA,
Sponsor: Takeda
Sex: All
Age: 18 - 70+
Code: NCT05677971
Phase3, Recruiting
Active & Responsive
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
for
Extensive Stage-small Cell Lung Cancer
Location: Birmingham AL, Nashville TN, Jacksonville FL, Tampa FL,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06362252
Phase1, Phase2, Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
Location: Birmingham AL, Hattiesburg MS, Atlanta GA, Memphis TN,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Birmingham AL, Atlanta GA, Charlotte NC, Cincinnati OH,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase1, Recruiting
Active & Responsive
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study